BCL2 and melanoma: It identified the stabilization ofHIF-1α protein as a mechanism by which bcl-2 induces the activation of HIF-1in hypoxic melanoma cells, through the impairment of ubiquitin-dependentHIF-1α degradation with the involvement of the β isoform of themolecular chaperone HSP90.